FT effective management option for older or comorbid patient. »
04/05/23

Patients staged as IVB p16 negative had 2-year DFS of 25%. »
01/23/23

DetermaIO may be useful to predict benefit of adding atezolizumab. »
04/04/23

Patients who had received prior BCG significantly more likely to progress. »
09/01/22

gBRCAm status associated with lower OS and lower PFS. »
10/13/22

Mean dose to hippocampus for treatment of carcinomas in head and neck region high enough to reduce neurocognitive functions. »
04/07/23

Patients with documented immune-related adverse event of dermatitis had improved OS. »
04/07/23

Results revealed powerful prophylactic activity of ATV. »
04/07/23

Patients with IMBC recommended additional adjuvant treatment. »
04/06/23

Validated diagnostic value of 4 genes and risk score model in clinical cohort. »
04/06/23